The purchase price was about $15.15 million.
Norm Merritt CEO Qualitest – PR
Israel startup Comply, a quality assurance specialist in pharma and digital health, has been acquired by Qualitest, an AI-powered, engineering-driven software testing and quality assurance company. The purchase price was NIS 50 million, about $15.15 million.
Founded in 2005, Comply provides quality assurance services for web, cloud and mobile applications related to digital health products. In particular, the company has focused on the validation of computerized systems, including enterprise IT and laboratory systems, as well as validation of IT infrastructure, such as information security and disaster recovery plans.
The challenge of transforming a mature technology organization to work in agile is massive.
Learn how the Scaled Agile COE structure can drive the #agile process through this whitepaper https://t.co/DtXDc0rjA6#ScaledAgile #SoftwareTesting #QualityEngineering pic.twitter.com/sf8lXfEpzW
— Qualitest (@Qualitest) April 8, 2021
“We’ve had our eyes on Comply for a while due to its reputation as a leader in providing software testing services to the growing pharma tech market,” said Norm Merritt, Qualitest CEO. “That’s why we are excited to bring them into the Qualitest family. We see a lot of potential in the pharma industry, and by integrating Comply’s expertise we can expand Qualitest’s footprint in this hot-growth area,” he added.
“Qualitest is a global leader in testing, which is why it’s the perfect partner to help us take our testing services worldwide,” said Gai Anbar, Founder and CEO at Comply. “We have been impressed with Qualitest’s position as the go-to provider for software testing. By joining forces, we can capitalize on our own expertise in providing the highest quality assurance for health and pharma businesses,” he added.
Founded in 1997, Qualitest offers a wide range of AI-powered quality engineering and testing solutions, designed to mitigate the business risk associated with software releases. Qualitest achieves this by deploying engagement models tailored to the precise testing needs of technology platforms in the technology, financial services, retail, telecom, healthcare, insurance, aerospace, media and utilities industries. It has operations in Israel (where it was founded), the US, UK, and Romania, and serves over 250 blue-chip customers worldwide.